• Molecular NameTriamcinolone
  • SynonymFluoxiprednisolone; Fluoxyprednisolone; Tiamcinolonum [INN-Latin]; Triamcinalone; Triamcinolona [INN-Spanish]; Triamcinolone acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide; Triamcinolonum [INN]
  • Weight394.439
  • Drugbank_IDDB00620
  • ACS_NO124-94-7
  • Show 3D model
  • LogP (experiment)1.2
  • LogP (predicted, AB/LogP v2.0)0.85
  • pkaN/A
  • LogD (pH=7, predicted)0.85
  • Solubility (experiment)0.0824 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.43
  • LogSw (predicted, AB/LogsW2.0)0.17
  • Sw (mg/ml) (predicted, ACD/Labs)0.15
  • No.of HBond Donors4
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds2
  • TPSA115.06
  • StatusFDA approved
  • AdministrationOral, topical, IM, intra-articular, intrasynovial
  • PharmacologyA synthetic corticosteroid
  • Absorption_value100.0
  • Absorption (description)Rapid absorption following oral administration
  • Caco_2N/A
  • Bioavailability23.0
  • Protein binding68.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life88 min
  • ExcretionFecal and renal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityLD50=>500mg/kg (in rats
  • LD50 (rat)N/A
  • LD50 (mouse)N/A